You can now read 5 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

Parexel unveils platform designed to make clinical drug trials more efficient

Parexel International Corp. announced Monday the launch of a platform that is designed to simplify the clinical trial process for experimental drugs.

Headquartered in Waltham, Parexel provides services to pharmaceutical companies looking to develop and commercialize new drugs.

Continue reading below

In a press release, Parexel said it is calling its new offering the Parexel MyTrials platform.

‘‘In recent years there has been an increase in the number of applications for managing the clinical trials process, but these independent systems are not necessarily compatible with each other, for example, forcing users to enter the same data multiple times in different applications,” Dr. Mark A. Goldberg, Parexel’s chief operating officer, said in a statement. “This disrupts optimal workflow and processes, resulting in an unintended loss of productivity. Sponsors and investigator site users are looking for a unified solution to plan, design, and conduct their clinical trial programs.  With the availability of Parexel MyTrials, users will have a single place to access a comprehensive suite of applications, tools, metrics, and reports through full data integration and application convergence.”

Parexel made its announcement as many life sciences companies converge on Boston, which is playing host this week to an industry convention known as BIO.

Chris Reidy can be reached at
Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
Please enter a valid email will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of